What is the Y-tunnus number of Suomen Lääkekehityskeskus Oy?

Suomen Lääkekehityskeskus Oy is registered with PRH / YTJ under Y-tunnus 3266907-5.

What is the revenue of Suomen Lääkekehityskeskus Oy?

Suomen Lääkekehityskeskus Oy reported revenue of EUR 603 in 2025.

How many employees does Suomen Lääkekehityskeskus Oy have?

Suomen Lääkekehityskeskus Oy employs 4 people as of the latest annual report.

Who is the CEO of Suomen Lääkekehityskeskus Oy?

Maarit Hannele Merla is Chief Executive Officer of Suomen Lääkekehityskeskus Oy, in role since 2024.

Who is the chairman of Suomen Lääkekehityskeskus Oy?

Ilpo Jaakko Tolonen chairs the board of Suomen Lääkekehityskeskus Oy, in role since 2026.

Where is Suomen Lääkekehityskeskus Oy headquartered?

Suomen Lääkekehityskeskus Oy's registered address is Lemminkäisenkatu 14-A363.

Riskpilot← Back to search

Sign inGet full access

Suomen Lääkekehityskeskus Oy

OYActive

Y-tunnus 3266907-5Lemminkäisenkatu 14A-14363, 20520 TurkuResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20224 employeeswww.ddcenter.fi

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2023	2024	2025
Revenue	0	1	1
Staff expenses	−29	−554	−554
EBITDA	−44	−789	−789
Depreciation & amort.	−0	−1	−1
EBIT	−44	−789	−789
Net financials	2	283	283
Profit before tax	−42	−507	−507
Tax	−0	−0	−0
Net profit	−42	−507	−507

Balance sheet

EUR thousands

Item	2023	2024	2025
Total assets	9 976	9 634	18 901
Equity	9 958	9 451	18 652
Long-term debt	0	0	0
Short-term debt	0	183	249
Total debt	0	183	249

Financial ratios

5-year trend

EBITDA margin

-130814.3%

This company

15.8%

Market median

-828039% vs market

20232025

Equity ratio

98.7%

This company

38.2%

Market median

+158% vs market

20232025

Return on equity

-2.7%

This company

18.4%

Market median

-115% vs market

20232025

Net profit margin

-84068.5%

This company

8.1%

Market median

-1037983% vs market

20232025

Asset turnover

0.00×

This company

1.12×

Market median

-100% vs market

20232025

Debt / equity

0.01×

This company

0.62×

Market median

+98% vs market

20232025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View PDF

Suomen Lääkekehityskeskus Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Suomen Lääkekehityskeskus Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Suomen Lääkekehityskeskus Oy